54AA Phase II Clinical Trials
Kisspeptin
The master upstream switch of the reproductive axis — a neuropeptide that governs GnRH pulsatility, testosterone, fertility, and sexual desire in both men and women.
In Plain English:
Kisspeptin is a naturally occurring neuropeptide your hypothalamus uses to send the 'start' signal to your reproductive system. Think of it as the ignition key for the hormone cascade: kisspeptin fires first, prompting the release of GnRH, which then triggers the pituitary to release LH and FSH, which finally tell the gonads to produce testosterone or estrogen. Discovered in 1996 as a melanoma metastasis suppressor (hence the name — coined at the Hershey, Pennsylvania chocolate factory town), it was later found to be the primary regulator of puberty onset and reproductive hormone cycling. In clinical research, intravenous infusions have restored menstrual cycles in women with hypothalamic amenorrhea, triggered ovulation for IVF, raised testosterone in hypogonadal men, and improved sexual brain activation in people with low libido — all without measurable adverse effects in published trials.
Research Maturity
Phase II Clinical Trials (~3,800 kisspeptin papers PubMed-indexed; 30+ human clinical studies+ Studies)
Focus
Endocrine Signaling
Fertility
Reproductive Health
Route
Intramuscular
IV
SubQ
Origin
Endogenous human neuropeptide encoded by the KISS1 gene on chromosome 1q32. First identified in 1996 at Penn State Hershey by Danny Welch's lab as a melanoma metastasis suppressor (KISS1 named after Hershey's Kisses). The peptide product, then called metastin, was shown in 2001 to be the natural ligand for the orphan G protein-coupled receptor GPR54 (KISS1R). Four bioactive isoforms are cleaved from the 145 amino acid prepro-kisspeptin precursor: KP-54 (the full circulating form), KP-14, KP-13, and KP-10 (the pharmacologically active C-terminal decapeptide).
Mechanism
Kisspeptin binds KISS1R (GPR54), a Gq/11-coupled receptor expressed on hypothalamic GnRH neurons. Receptor activation triggers phospholipase C, generating inositol triphosphate (IP3) and diacylglycerol (DAG), which elevate intracellular calcium and activate protein kinase C. This causes membrane depolarization and increased firing rate of GnRH neurons, driving pulsatile GnRH secretion into the pituitary portal circulation. GnRH then stimulates LH and FSH release from anterior pituitary gonadotrophs — LH rising 2–3-fold acutely, FSH to a lesser and more variable extent. KP-54 neurons in the hypothalamic arcuate nucleus also co-express neurokinin B and dynorphin (the 'KNDy' neurons), creating a self-regulating pulse generator. Independently of the HPG axis, kisspeptin projects to limbic regions (medial amygdala, bed nucleus of the stria terminalis) governing sexual arousal and aversion, explaining its direct effects on sexual brain processing that are partially independent of testosterone.
Outcome
In randomized clinical trials: restored pulsatile LH secretion and menstrual cycling in hypothalamic amenorrhea; triggered oocyte maturation (live births documented) in IVF; elevated serum testosterone into the normal physiological range in hypogonadal men with type 2 diabetes; increased penile tumescence by up to 56% vs. placebo in men with hypoactive sexual desire disorder; enhanced sexual brain activation on fMRI in women with HSDD. No adverse events reported across published human trials.
